2023
DOI: 10.1016/j.jval.2023.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Adaptive Health Technology Assessment: A Scoping Review of Methods

Cassandra Nemzoff,
Hiral A. Shah,
Lieke Fleur Heupink
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…HTAIn would work with key decision-makers and strategic stakeholders at national and state levels in India to inform high impact policy decisions and practices that deliver on India's health system goals. Conversely, HTAIn's processes would be adequately rapid and responsive to match these stakeholders' expectations (eg, by developing and testing adaptive HTA approaches 8 ) and that any weaknesses in such processes would be anticipated, identified and resolved collaboratively with said stakeholders.…”
Section: Transformative Influencementioning
confidence: 99%
“…HTAIn would work with key decision-makers and strategic stakeholders at national and state levels in India to inform high impact policy decisions and practices that deliver on India's health system goals. Conversely, HTAIn's processes would be adequately rapid and responsive to match these stakeholders' expectations (eg, by developing and testing adaptive HTA approaches 8 ) and that any weaknesses in such processes would be anticipated, identified and resolved collaboratively with said stakeholders.…”
Section: Transformative Influencementioning
confidence: 99%
“…Also, BRA can play a central role in postcommercialisation monitoring studies and adaptive HTA. 15 In summary, expanding the scope of BRA and incorporating these elements can improve and fortify the collaboration between regulatory agencies and HTA authorities, resulting in more comprehensive, transparent and informed evaluations of health technologies. 16 There is still a gap in the literature regarding the availability of methodological guidelines and publications on methods for BRA and their characteristics in the context of HTA and at population decision-making levels.…”
Section: Strengths and Limitations Of This Studymentioning
confidence: 99%
“…Also, BRA can play a central role in postcommercialisation monitoring studies and adaptive HTA. 15 In summary, expanding the scope of BRA and incorporating these elements can improve and fortify the collaboration between regulatory agencies and HTA authorities, resulting in more comprehensive, transparent and informed evaluations of health technologies. 16 …”
Section: Introductionmentioning
confidence: 99%